Hill-Rom Holdings

Hill-Rom Holdings is a medical technology company. The company focuses on patient care solutions that improve clinical and economic outcomes. The company's products and services are: Patient Support Systems, which include a variety of specialty frames and surfaces, patient mobility solutions, non-invasive therapeutic products and surfaces, and its communications technologies and software solutions; Front Line Care, which includes its patient monitoring and diagnostics products from Welch Allyn Holdings, Inc. and Mortara Instruments, Inc. and its respiratory health products; and Surgical Solutions, which include surgical tables, lights, and pendants utilized within the operating room setting.
  • TickerHRC
  • ISINUS4314751029
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

Hill-Rom Holdings, Inc. - December 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

ValuEngine Rating and Forecast Report for HRC

ValuEngine Rating and Forecast Report for HRC

Kevin Huang

Hill-Rom Holdings, Inc.

ValuEngine Rating and Forecast Report for HRC

ValuEngine Rating and Forecast Report for HRC

Kevin Huang

Hill-Rom Holdings, Inc.

Hill-Rom Holdings, Inc. - December 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Hill-Rom Holdings, Inc. - September 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Hill-Rom Holdings, Inc.: Covenant Quality Post-Sale Snapshot: $425m 4.375% Senior Notes due 2027

The covenant package of Hill-Rom Holdings, Inc. (“Issuer”) provides weakest-level protection, reflecting a CQ score of 4.36.

Moody's assigns Ba3 rating to Hill-Rom's new unsecured notes

Rating Action: Moody's assigns Ba3 rating to Hill-Rom's new unsecured notes. Global Credit Research- 05 Sep 2019. New York, September 05, 2019-- Moody's Investors Service assigned a Ba3 rating to Hill-Rom Holdings, Inc.' s new senior unsecured notes.

Hill-Rom Holdings, Inc.: Update to credit analysis

Hill-Rom's credit profile reflects its moderately high financial leverage, offset by its leading market position and product and geographic diversification.

Kevin Huang

Hill-Rom Holdings, Inc.

Kevin Huang

Hill-Rom Holdings, Inc.

Kevin Huang

Hill-Rom Holdings, Inc.

Kevin Huang

Hill-Rom Holdings, Inc.

Kevin Huang

Hill-Rom Holdings, Inc.

Two Directors sold after exercising options/sold 126,241 shares at between 82.595USD and 82.990USD.

Two Directors at Hill-Rom Holdings Inc sold after exercising options/sold 126,241 shares at between 82.595USD and 82.990USD. The significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading ...

ValuEngine Rating and Forecast Report for HRC

ValuEngine Rating and Forecast Report for HRC

ValuEngine Rating and Forecast Report for HRC

ValuEngine Rating and Forecast Report for HRC

ValuEngine Rating and Forecast Report for HRC

ValuEngine Rating and Forecast Report for HRC

ValuEngine Rating and Forecast Report for HRC

ValuEngine Rating and Forecast Report for HRC

Kevin Huang

Hill-Rom Holdings, Inc.

MarketLine Department

Invacare Corporation - Strategy, SWOT and Corporate Finance Report

Summary Invacare Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. KeyHighlights Invacare Corporation (Invacare or 'the company') produces, distributes, and markets medical equipment including custom manual wheelchairs, power wheelchairs, manual wheelchairs, pressure relieving mattresses, respiratory therapy product lines such as non-delivery oxygen and stationary ox...

MarketLine Department

Getinge AB - Strategy, SWOT and Corporate Finance Report

Getinge AB - Strategy, SWOT and Corporate Finance Report Summary Getinge AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Getinge AB (Getinge or 'the group') is a global provider of products and systems for healthcare and life science industries. The company designs and develops medical equipment and solution for surgery, intensive care, infection control, ca...

MarketLine Department

Getinge AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Getinge AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Getinge AB since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highlights ...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of Consumer Cyclical names continue to reflect leadership. (ex. SBUX, RRGB, MCD, PZZA, and ROST.) • The Financial Sector has a number of attractive names developing major bases and staging RS reversals. (ex. SIVB, STT, AXP, SPGI, CME, GS, and JEF) • The Technology Sector has a number of technically attractive constituents. (ex. AMD, OLED, MPWR, CRUS, BR, FIS, VRSN, SAIC, LDOS, AAOI, BELFB, FARO, STX, and AAPL) .

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Many Semiconductor and Semi-Suppliers stocks are reversing downtrends or breaking out of bases. • A number of Software related names are showing RS leadership. • Another bright spot are the Electronic Component suppliers.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Macro Vision: Sector Synopsis

Investors continue to prefer the stability of the U.S. relative to emerging markets. The decline in emerging markets and their currencies suggest global risk aversion. U.S. equity markets are, by contrast, not showing any significant signs of coming unhinged as a result of this rout in emerging markets. We continue to monitor the following to assess the health of the U.S. market: • U.S. Dollar: The U.S. dollar remains the de-facto world currency and has aided the U.S. equity markets in staying a step above the malaise in global markets. However we would prefer to see stabilization in emerg...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch